J. Swadzba

发表

Avidity of anti-β2-glycoprotein I antibodies in patients with antiphospholipid syndrome

S. Čučnik, T. Kveder, B. Božič, 2012, Lupus.

Thrombin Generation Measured Ex Vivo Following Microvasculor Injury Is Increased in SLE Patients with Antiphospholipid-protein Antibodies

A. Szczeklik, A. Szczeklik, J. Musial, 1997, Thrombosis and Haemostasis.

An international multicentre‐laboratory evaluation of a new assay to detect specifically lupus anticoagulants dependent on the presence of anti‐beta2‐glycoprotein autoantibodies

P. D. de Groot, S. Čučnik, B. Božič, 2011, Journal of thrombosis and haemostasis : JTH.

Revised classification criteria for antiphospholipid syndrome and the thrombotic risk in patients with autoimmune diseases

A. Szczeklik, J. Swadzba, T. Iwaniec, 2007, Journal of thrombosis and haemostasis : JTH.

Immunoreactivity and avidity of IgG anti-β2-glycoprotein I antibodies from patients with autoimmune diseases to different peptide clusters of β2-glycoprotein I

Y. Shoenfeld, S. Čučnik, B. Božič, 2015, Immunologic research.

The avidity of anti-β2-glycoprotein I antibodies in patients with or without antiphospholipid syndrome: a collaborative study in the frame of the European forum on antiphospholipid antibodies

S. Čučnik, T. Kveder, B. Božič, 2011, Lupus.

Lupus anticoagulant: performance of the tests as recommended by the latest ISTH guidelines

P. D. de Groot, J. Musial, J. Swadzba, 2011, Journal of thrombosis and haemostasis : JTH.

Increased level of tumor necrosis factor-α in patients with antiphospholipid syndrome: marker not only of inflammation but also of the prothrombotic state

J. Musial, J. Swadzba, T. Iwaniec, 2011, Rheumatology International.

Summary of the 9th meeting of the European Forum on Antiphospholipid Antibodies

J. Musial, J. Swadzba, J. Kolodziejczyk, 2014, Lupus.

Antithrombotic actions of statins.

A. Szczeklik, J. Musial, M. Jankowski, 2001, Medical science monitor : international medical journal of experimental and clinical research.

Head-to-Head Comparison of 5 Anti-SARS-CoV-2 Assays Performance in One Hundred COVID-19 Vaccinees, over an 8-Month Course

J. Swadzba, Tomasz Anyszek, Andrzej Panek, 2022, Diagnostics.

Evaluation of phosphatidylserine-dependent antiprothrombin antibody testing for the diagnosis of antiphospholipid syndrome: results of an international multicentre study

G. Ruiz-Irastorza, R. Cervera, M. Tomšič, 2017, Lupus.

Anticardiolipin, anti-beta(2)-glycoprotein I, antiprothrombin antibodies, and lupus anticoagulant in patients with systemic lupus erythematosus with a history of thrombosis.

A. Szczeklik, J. Musial, M. Jankowski, 1997, The Journal of rheumatology.

Inhibition of thrombin generation by aspirin is blunted in hypercholesterolemia.

A. Szczeklik, A. Szczeklik, M. Duplaga, 1996, Arteriosclerosis, thrombosis, and vascular biology.

Antiphospholipid Antibodies – Detection and Clinical Importance

J. Swadzba, J. Kolodziejczyk, J. Swadźba, 2012 .

4 Antiphospholipid Antibodies – Detection and Clinical Importance

J. Swadzba, J. Kolodziejczyk, J. Swadźba, 2012 .

Valine/Leucine247 polymorphism of β2-glycoprotein I in patients with antiphospholipid syndrome: lack of association with anti-β2-glycoprotein I antibodies

M. Sanak, J. Musial, J. Swadzba, 2006, Lupus.

Plasma fibrinolytic activity in healthy subjects with high and low lipoprotein(a) concentrations.

A. Szczeklik, J. Swadzba, A. Undas, 1992, Thrombosis research.

Expansion of a SARS-CoV-2 Delta variant with an 872 nt deletion encompassing ORF7a, ORF7b and ORF8, Poland, July to August 2021

Pawel P. Labaj, K. Pyrć, K. Bieńkowska-Szewczyk, 2021, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

More on: the debate on antiphospholipid syndrome classification criteria

J. Musial, J. Swadzba, J. Swadźba, 2009, Journal of thrombosis and haemostasis : JTH.